The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
From what they know about the new strain, the Antigen test should be fine. Antigen test usually will detect the Nucleocapsid protein. From what we are told about the new strain this is unchanged.
Regarding the antibody test, comment from Oxford/AstaZenica will help but it is unlikely that minor mutations will significantly differ in genetic code that antibody response becomes ineffective. The antibody tests may become even more important
Haha yeah it's the DHSC office in leeds
Spot on Tonic. Even 500k tests a week is worth a lot more than current MCAP.
Bought more this morning. A few in ISA, but sub what CK paid i'm adding on leverage. So grateful to get this price at this time just a few months from 2m tests per week. We have 2 shots at bagging from this level with MHRA approval of ABC19 and Antigen test. Both together this will be in a whole new league. Widley rumoured AZN vaccine will be approved next week, so antibody test news must be on high alert. Antigen tests are in more demand than ever and quality ones even more so.
There are a few missing pieces to this. We know these tests are not accurate and are likely to be on the low end of performance.
Sample size is very low so % can easily be escalated.
The surveillance is in asymptomatic people where the sensitivity is likely to be lower than those with symptoms.
The point is these test are being used locations.circumstances/scale where PCR is not possible. it is better to pick up 50% of cases than zero right?
Far too much money is being spent on inferior tests, he has that right. But the alternative in reality is wait a bit longer for tests. The high quality tests are not yet available on the scale required. Is it not better to iron out the processes and start learning about the effectiveness based on the inferior tests so that when the better tests are available we are already in a position to start benefiting?
If the government weren't using them they would be criticised for not using available tools to get things moving again.
It's disappointing when people are setting out with a purpose of finding floors are manipulating data for an agenda. We are talking about a 700 sample of 1 uni for which which we have little information about the control.
But the most important thing is in Mologic i think we are in exactly the right place to ensure we have quality tests. It's good to have other tests out of inferior quality first which opens the door for Mologic. But the likelihood is we are still several months away from the UK being able to deliver sufficient quantity of high quality tests, even if a 100% accurate test came to light today.How long do you keep waiting for the perfect test?
No the rule is news has to be announced as soon as possible. They can always hold things up but not putting signatures on things not formalising or finalising things. Obviously Colin would have had inside information when he bought his shares, he would have had to agree with the Nomad that he can buy a reasonable amount. I suspect it was an amount that was not overly successive to overly profit but a reasonable amount given the share price.
Omega cannot announce news on Mologic test before Mologic agree.
The commercial environment for Omega just gets stronger and stronger. They should be up to 500k tests a week if not by now any day now, and it grwos very quickly from there.
MHRA approval may well come before the year is out...
And where is the Antigen news. TT under way so we are being denied a 200% rise plus just based on that confirmation.
When the news comes i really think it is going to exceed expectations. At the end of the day Omega have done the leg work to get the capacity on board, kit is on board and on order and recruitment is off the chart. They are in an enviable position of having what could be the 2 most sought after covid tests.
Grateful to be topping up at these levels. My position is now locked and loaded for an incredible 2021. Just needs the regulators and government to open up the lateral flow market and then there will be no stopping it.
JDT - because it's a deal with a company turning over 10-15m a year, so it's not going to be worth many millions to Avacta.
I agree this is a good business model, but nothing has come to a conclusion where you get a big bang breakthrough moment. It's all development and highly speculative. As i said i think this is a good honest deal and pleases me a lot more than over promises elsewhere.
This looks a much more honest and fitting type of deal for where avacta are at with Affimers than the huge potential highly conditional promises of multi millions.
Wondering if this could be the source of the development income from the "as yet unnamed source"
Who are in partnership with Mologic. They say it will be made in Bedford. Mologic are the only ones in Bedford. Theres no way a company of 3 people have achieved this on their own. Question is is this test and Mologic's test one and the same? Or are mologic working on this in tandem with their own test?
https://www.vatic.health/news/vatic-announce-partnership-with-mologic
lol im not sure this guy was key for Omega to get their tests out! What exactly is he going to do as Cytiva did the development, BBI and Abingdon are doing the manufacturing? Avacta should have started to build an in house team a long time ago with their own manufacturing capacity.
They are working with Mologic so they have the most important thing right, pick the best partners.
https://www.vatic.health/news/vatic-announce-partnership-with-mologic
I think he is trying to make a valid point, but doing an experiment to test for something a test is not designed to do is pointless. It is like testing a car at the bottom of the ocean.
More to the point..... is he hinting a huge contract is coming out later today?
I don't see too much significance in the 25th Dec break clause. If it;'s in both parties interest to extend then they will extend. The question is, once the 25th Dec lapses, do they no longer require approval to sell to third parties? If so then it is in the DHSC best interest to conclude before then.
Kong - it doesn't matter when the test is from i share it for the picture not the content.
They have not given them £300m. It is "potentially worth over $300m to Avacta." It is all "could" "Potential" with no idea of the chance of success communicated but it is all development and experimental and not guaranteed. I agree this looks promising. I just would like to see them actually achieve some of these things before claiming success, same with the covid test. Deliver and then brag about it not the other way around.
The QR code is a sticker.
It is the Innova test
https://thestateindia.com/2020/10/20/coronavirus-uk-government-secures-up-to-20m-15-minute-test-kits/
Kong - it is understandable he talks with great enthusiasm about the company he founded. I suspect in the early stage he never expected the valuation to take off as quickly as it did, and has been under pressure since. He did the right thing raising capital it was too good an opportunity to not do it. But i am sorry he has at no point reasonably communicated the realistic chances of success. Everything has been talked about as a shoo in.
Your questions:
Again I take on board some of what you say but if you are seriously against this share why do you own shares in the company ? I do not own shares and have never held a position long or short. It's on my watch list and i have researched it probably much more than most people that post here
If you don’t, why do you come on here to be so antagonistic towards shareholders . I have no interest in being friend or foe, only calling it how i see it.
What is your reason behind your comments ? I dont believe the balance of risk/reward is fair here. I see far too much mistruths and i am entitled to add my opinion.
Why does it matter to you if the share price collapses ? Personally it does not impact me. I dont want to see other PIs lose money based on failed promises of CEOs. We have all been there. I wish i had listened to counter arguments in other stocks in the past.
And why does it matter if it risers several fold if you don’t own any shares ? It doesn't matter i will genuinely be happy for you if it happens but the chances of this are much much lower than the general comment on here would have you beleive.
The simple fact is this company have no track record of diagnostics devices used in real life, yet the single largest commercial opportunity comes along and they have you believing that they are going to lead the world when every expert scientist in diagnostics with years of proven success are working towards the same goal.
Take it or leave it filter me if you like or dont like